Nature Medicine· Jakob Wirbel·· 8 天前AI 评分53
两种GVHD预防方案的肠道菌群影响:BMT CTN 1801 III期RCT伴随研究
Effect of two common GVHD prophylaxis regimens on the gut microbiome in a randomized phase 3 trial
AI 导读
作为III期RCT BMT CTN 1703的预设伴随研究,BMT CTN 1801比较了两种常见GVHD预防方案对肠道微生物组的影响。植入期微生物组多样性未与非复发死亡率相关,但二次分析显示基线微生物组多样性与临床结局存在关联。
正文
Nature Medicine, Published online: 12 November 2026; doi:10.1038/s41591-026-04712-z
In a prespecified companion study (BMT CTN 1801) of the randomized phase 3 BMT CTN 1703 trial comparing two common GVHD prophylaxis regimens, microbiome diversity at engraftment did not associate with non-relapse mortality, but secondary analyses found baseline microbiome diversity was associated with clinical outcomes.
来源:Nature Medicine · nature.com